Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost
Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2015.08.006
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Elsevier BV